DK512184A - 5(3)-amino-6(substitueret phenyl)2,3(2,5)-dihydro-3(5)-imino-2-alkyl-1,2,4-triaziner samt fremgangsmaade til fremstilling deraf - Google Patents

5(3)-amino-6(substitueret phenyl)2,3(2,5)-dihydro-3(5)-imino-2-alkyl-1,2,4-triaziner samt fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK512184A
DK512184A DK512184A DK512184A DK512184A DK 512184 A DK512184 A DK 512184A DK 512184 A DK512184 A DK 512184A DK 512184 A DK512184 A DK 512184A DK 512184 A DK512184 A DK 512184A
Authority
DK
Denmark
Prior art keywords
triazines
imino
dihydro
procedures
amino
Prior art date
Application number
DK512184A
Other languages
Danish (da)
English (en)
Other versions
DK512184D0 (da
Inventor
Geoffrey Allan
Alistair Ainslie Miller
David Alan Sawyer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK512184D0 publication Critical patent/DK512184D0/da
Publication of DK512184A publication Critical patent/DK512184A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK512184A 1983-10-27 1984-10-26 5(3)-amino-6(substitueret phenyl)2,3(2,5)-dihydro-3(5)-imino-2-alkyl-1,2,4-triaziner samt fremgangsmaade til fremstilling deraf DK512184A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838328757A GB8328757D0 (en) 1983-10-27 1983-10-27 Chemical compounds

Publications (2)

Publication Number Publication Date
DK512184D0 DK512184D0 (da) 1984-10-26
DK512184A true DK512184A (da) 1985-04-28

Family

ID=10550834

Family Applications (1)

Application Number Title Priority Date Filing Date
DK512184A DK512184A (da) 1983-10-27 1984-10-26 5(3)-amino-6(substitueret phenyl)2,3(2,5)-dihydro-3(5)-imino-2-alkyl-1,2,4-triaziner samt fremgangsmaade til fremstilling deraf

Country Status (21)

Country Link
US (1) US4649139A (es)
EP (1) EP0142306A3 (es)
JP (1) JPS60109577A (es)
KR (1) KR890000991B1 (es)
AU (1) AU564667B2 (es)
CA (1) CA1261328A (es)
DD (1) DD224033A5 (es)
DK (1) DK512184A (es)
ES (1) ES8606304A1 (es)
FI (1) FI844212L (es)
GB (1) GB8328757D0 (es)
GR (1) GR80723B (es)
HU (1) HU191566B (es)
IL (1) IL73332A (es)
MC (1) MC1628A1 (es)
NZ (1) NZ210000A (es)
PH (1) PH21926A (es)
PL (1) PL144899B1 (es)
PT (1) PT79416B (es)
SU (1) SU1371500A3 (es)
ZA (1) ZA848388B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9218113D0 (en) * 1992-08-26 1992-10-14 Lilly Industries Ltd Pharmaceutical compounds
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
US6639072B1 (en) 2000-01-03 2003-10-28 Rpg Life Sciences Limited Process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
IL134730A (en) * 2000-02-25 2003-10-31 Chemagis Ltd Process for preparing substituted benzoyl cyanide amidinohydrazones
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
GB0613836D0 (en) 2006-07-13 2006-08-23 Univ Greenwich New medical use of triazine derivatives
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
GB0800741D0 (en) 2008-01-16 2008-02-20 Univ Greenwich Cyclic triazo and diazo sodium channel blockers
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
GB2471713A (en) 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
GB2471729A (en) * 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
JP2018524302A (ja) 2015-06-12 2018-08-30 ユニバーシティ オブ グリニッジ インターフェロン‐γ阻害剤としてのトリアジン誘導体
CN109810070B (zh) * 2019-01-29 2022-03-15 太原理工大学 一种含有双酰氧基结构的三嗪酮衍生物及其制备方法和应用
GB202006080D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Cytokine storm syndrome
GB202006076D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Interleukin inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB759014A (en) * 1952-02-26 1956-10-10 Wellcome Found Improvements in triazines and their manufacture
BG15760A3 (bg) * 1968-06-29 1976-06-21 Неизвестен Метод за получаване на производни на 5-имино- 1, 2, 4- триазина
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
DE2003144C3 (de) * 1970-01-24 1980-01-10 Bayer Ag, 5090 Leverkusen 5-Imino-6-alkyl-1^2,4-triazin-Derivate und Verfahren zu deren Herstellung
GR68380B (es) * 1979-06-01 1981-12-28 Wellcome Found
EP0021120B1 (en) * 1979-06-01 1983-04-06 The Wellcome Foundation Limited 3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same

Also Published As

Publication number Publication date
ZA848388B (en) 1986-06-25
PT79416B (en) 1986-11-13
EP0142306A2 (en) 1985-05-22
AU564667B2 (en) 1987-08-20
ES537104A0 (es) 1986-04-16
AU3475884A (en) 1985-05-09
DK512184D0 (da) 1984-10-26
JPS60109577A (ja) 1985-06-15
MC1628A1 (fr) 1985-09-26
HU191566B (en) 1987-03-30
IL73332A (en) 1988-06-30
DD224033A5 (de) 1985-06-26
NZ210000A (en) 1987-08-31
HUT36102A (en) 1985-08-28
SU1371500A3 (ru) 1988-01-30
FI844212L (fi) 1985-04-28
US4649139A (en) 1987-03-10
EP0142306A3 (en) 1986-11-20
KR850002964A (ko) 1985-05-28
GR80723B (en) 1985-02-07
PL144899B1 (en) 1988-07-30
GB8328757D0 (en) 1983-11-30
KR890000991B1 (ko) 1989-04-15
ES8606304A1 (es) 1986-04-16
PL250213A1 (en) 1985-12-03
FI844212A0 (fi) 1984-10-26
IL73332A0 (en) 1985-01-31
PH21926A (en) 1988-04-08
CA1261328A (en) 1989-09-26
PT79416A (en) 1984-11-01

Similar Documents

Publication Publication Date Title
DK512184A (da) 5(3)-amino-6(substitueret phenyl)2,3(2,5)-dihydro-3(5)-imino-2-alkyl-1,2,4-triaziner samt fremgangsmaade til fremstilling deraf
FI820856L (fi) 2-fenoxialkyl-1,2,4-triazol-3-on antidepressiver
ATE35888T1 (de) N-phenylsulfonyl-n'-pyrimidinyl- und triazinylharnstoffe.
DE3466986D1 (de) N-phenylsulfonyl-n'-pyrimidinyl- and -triazinylurea
DK273587A (da) 1,5-diaryl-3-substituerede pyrazoler samt fremgangsmaade til fremstilling deraf
FI842317A0 (fi) Spiralvaev med liten genomslaepplighet samt foerfarande.
FI844777A0 (fi) 2,2'-iminobisetanolderivat.
DK80291A (da) 1,3,9,9a-tetrahydro-imidazooe4,5-baaquinolin-2-oner samt fremgangsmaade til fremstilling deraf
FI902233A0 (fi) Foerfarande foer tillverkning av folieaemnen foer vikta askar foersedda med vikelfoenster respektive av saodana askar samt motsvarande anordning.
TR22859A (tr) Suebstituee edilmis 2,6,suebstituee piridin bilesikleri
DK161327C (da) Substituerede 2-piperazinopteridiner, fremgangsmaade til fremstilling deraf samt laegemidler indeholdende forbindelserne
ES532458A0 (es) 2-fenil sustituido-4,5,6,7-tetrahidro-2h-isoindol-1,3-diona
FI840747A0 (fi) Kinolonkarbonsyror, foerfarande foer deras framstaellning samt dessa innehaollande antibakteriella aemnen
ES533537A0 (es) Triazol (2,3-c)pirimidin-aminas(-amidas)
FI834770A (fi) Ljuskaensligt blandkondensat samt med hjaelp av detta framstaelld ljuskaensligt kopiematerial.
DK250984A (da) 2,4-dihydro-5-((substitueret)phenyl)-4,4-disubstitueret-3h-pyrazol-3-oner
DK431185A (da) Substituerede quinazolindioner samt fremgangsmaade til fremstilling deraf
FI843056A0 (fi) Ask samt foerfarande och anordning foer framstaellning av askar.
FI843110A (fi) 4'-halogenantracyklinglykosid.
DK135184A (da) Triazol(4,3-c)- og triazol(1,5-c)pyrimidiner
FI822999L (fi) 3'-substituerade 5'-(2-amino-4-pyridyl)-1',2',4'-triazoler
FI842338A (fi) 2-azabicyklo/2.2.2./oktanderivat, foerfarande foer framstaellning av dessa samt dessa innehaollande farmaceutiska aemnen.
IT8421955A0 (it) 2-metil-4'-isopropil-2-pentenoilanilide.
DK12084D0 (da) Substituerede carboxy-thiazolo (3,2-a) pyrimidinderivater samt fremgangsmade til fremstilling heraf
FI830994A0 (fi) 1,2,4-triazol-1-ylpropionitriler, foerfarande foer framstaellning av dessa foereningar samt dessa innehaollande biosidpreparat

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment